Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

NCT00019695 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

NIH

Sponsor class

Conditions

Stage IV Prostate Cancer
Bone Metastases
Adenocarcinoma of the Prostate
Recurrent Prostate Cancer

Interventions

DRUG: alendronate sodium
DRUG: ketoconazole

Sponsor

National Cancer Institute (NCI)